BIOSCIENCE REPORTS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-09-07 Doc-L

各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？

136 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2019-09-07 效率

这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表:
CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04

133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04

133 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-08-06 1477da0bm07暂无昵称

为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛

122 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-06-26 洛洛仔

作为审稿人毙了一篇纯生信的论文

100 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-04-17 14618280m43暂无昵称

修回的文章大概会等多久有消息啊

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2023-04-28 不想发blue的科研民工来自四川省

为啥这个期刊去年很多文章都没有被sci收录呢

31 0

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2022-09-23 ms4000001680289394

今年会不会是预警呢？

44 0

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-08-23 lovetcm

审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0
偏重的研究方向：生物医学;生物综合
经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。
我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。
从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！

116 0

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-05-19 科研二狗

这个杂志看运气，运气好，很快，运气不好，一年半载被拒也

95 0

[GetPortalCommentsPageByObjectIdResponse(id=883417, encodeId=ecab88341ef6, content=各位大咖，Manuscript accepted后马上又处于in review状态，意味着什么呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c1251930422, createdName=Doc-L, createdTime=Mon Sep 07 22:01:10 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589091, encodeId=7e3f589091a6, content=修回的文章大概会等多久有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6dfa5111735, createdName=14618280m43暂无昵称, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128897, encodeId=cfda212889e5f, content=为啥这个期刊去年很多文章都没有被sci收录呢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=不想发blue的科研民工, createdTime=Fri Apr 28 07:38:19 CST 2023, time=2023-04-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2090035, encodeId=33be2090035cf, content=今年会不会是预警呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Fri Sep 23 21:23:20 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=)]

2020-05-14 老鱼故事123

好人一生pingamhanbin0827_86788705 2019-11-05 发表::
好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表:
好人一生平安

hanbin0827_86788705 2019-11-05 发表:: 好人一生平安

69 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务